Comparison of Volume Controlled Ventilation and Pressure Controlled Ventilation in Laparoscopic Bariatric Surgery
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03758937 |
|
Recruitment Status :
Completed
First Posted : November 29, 2018
Last Update Posted : November 29, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Bariatric Surgery | Procedure: volume-controlled ventilation Procedure: pressure-controlled ventilation | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 62 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Other |
| Official Title: | Comparison of Volume Controlled Ventilation and Pressure Controlled Ventilation in Terms of Respiratory Mechanics in Laparoscopic Bariatric Surgery |
| Actual Study Start Date : | April 1, 2016 |
| Actual Primary Completion Date : | April 1, 2017 |
| Actual Study Completion Date : | August 1, 2017 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: volume-controlled ventilation group
During the operation, necessary interventions were made by following the algorithm. Hemodynamic and mechanical ventilation parameters of patients were recorded 5 minutes after induction, 30 minutes after pneumoperitoneum and at the end of surgery and were performed arterial blood gas analysis.
|
Procedure: volume-controlled ventilation |
|
Active Comparator: pressure-controlled ventilation group
During the operation, necessary interventions were made by following the algorithm. Hemodynamic and mechanical ventilation parameters of patients were recorded 5 minutes after induction, 30 minutes after pneumoperitoneum and at the end of surgery and were performed arterial blood gas analysis.
|
Procedure: pressure-controlled ventilation |
- Partial oxygen pressure [ Time Frame: 5 minutes after induction ]Assessed 5 minutes after induction by using arterial blood gas analysis.
- Partial oxygen pressure [ Time Frame: 30 minutes after pneumoperitoneum ]Assessed 30 minutes after pneumoperitoneum by using arterial blood gas
- Partial oxygen pressure [ Time Frame: through surgery completion, an average of 90 minutes ]Assessed through surgery completion, an average of 90 minutes by using arterial blood gas
- Partial carbon dioxide pressure [ Time Frame: 5 minutes after induction, 30 minutes after pneumoperitoneum, through surgery completion, an average of 90 minutes ]Assessed 5 minutes after induction, 30 minutes after pneumoperitoneum and through surgery completion, an average of 90 minutes by using arterial blood gas analysis.
- Partial carbon dioxide pressure - end-tidal carbon dioxide pressure [ Time Frame: 5 minutes after induction, 30 minutes after pneumoperitoneum, through surgery completion, an average of 90 minutes ]Assessed 5 minutes after induction, 30 minutes after pneumoperitoneum and through surgery completion, an average of 90 minutes by using arterial blood gas analysis and end-tidal monitor.
- Peak airway pressure [ Time Frame: 5 minutes after induction, 30 minutes after pneumoperitoneum, through surgery completion, an average of 90 minutes ]Assessed 5 minutes after induction, 30 minutes after pneumoperitoneum and through surgery completion, an average of 90 minutes by using the patient monitor.
- Dynamic compliance [ Time Frame: 5 minutes after induction, 30 minutes after pneumoperitoneum, through surgery completion, an average of 90 minutes ]Assessed 5 minutes after induction, 30 minutes after pneumoperitoneum and through surgery completion, an average of 90 minutes by using formula (Tidal volume/peak airway pressure - Positive end-expiratory pressure)
- Inspired oxygen pressure / Fractional oxygen ratio [ Time Frame: 5 minutes after induction, 30 minutes after pneumoperitoneum, through surgery completion, an average of 90 minutes ]Assessed 5 minutes after induction, 30 minutes after pneumoperitoneum and through surgery completion, an average of 90 minutes
- Alveolar-arterial oxygen gradient pressure [ Time Frame: 5 minutes after induction, 30 minutes after pneumoperitoneum, through surgery completion, an average of 90 minutes ]Assessed 5 minutes after induction, 30 minutes after pneumoperitoneum and through surgery completion, an average of 90 minutes by using formula (D(A-a) O2).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 18 years or above,
- ASA II patients
- BMI > 40 kg / m2
- No serious comorbidity.
Exclusion Criteria:
- Unstable patients during the operation
- The requirement for mechanical ventilation in the postoperative period.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03758937
| Turkey | |
| Antalya Traning and Research Hospital | |
| Antalya, Turkey | |
| Study Director: | Erhan Ozyurt, MD | Antalya Training and Research Hospital |
| Responsible Party: | Antalya Training and Research Hospital |
| ClinicalTrials.gov Identifier: | NCT03758937 |
| Other Study ID Numbers: |
AntalyaTRH31 |
| First Posted: | November 29, 2018 Key Record Dates |
| Last Update Posted: | November 29, 2018 |
| Last Verified: | November 2018 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
bariatric surgery volume-controlled ventilation pressure-controlled ventilation |

